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A B S T R A C T
Research, collaboration, and knowledge exchange are critical to global efforts to tackle antimicrobial
resistance (AMR). Different healthcare economies are faced with different challenges in implementing
effective strategies to address AMR. Building effective capacity for research to inform AMR-related
strategies and policies is recognised as an important contributor to success. Interdisciplinary, intersector,
as well as international collaborations are needed to span global to local efforts to tackle AMR. The
development of reciprocal, long-term partnerships between collaborators in high-income and in low-
and middle-income countries (LMICs) needs to be built on principles of capacity building. Using case
studies spanning local and international research collaborations to codesign, implement, and evaluate
strategies to tackle AMR, we have evaluated and build upon the ESSENCE criteria for capacity building in
LMICs. The first case study describes the local codesign and implementation of antimicrobial stewardship
(AMS) in the state of Kerala in India. The second case study describes an international research
collaboration investigating AMR surgical patient pathways in India, the UK, and South Africa. We describe
the steps undertaken to develop robust, agile, and flexible AMS research and implementation teams.
Notably, investing in capacity building ensured that the programmes described in these case studies were
sustained through the current severe acute respiratory syndrome coronavirus pandemic. Describing the
strategies adopted by a local and an international collaboration to tackle AMR, we provide a model for
capacity building in LMICs that can support sustainable and agile AMS programmes.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Antimicrobial resistance (AMR), leading to a decrease in
effectiveness of antibiotics, is a major global health threat (Holmes
et al., 2015). The 2014 ‘Review on antimicrobial resistance’, Chaired
by Jim O’Neill, estimated that 10 million deaths could be attributed
to AMR by 2050, with the majority of these deaths predicted to be* Corresponding author at: NIHR Health Protection Research Unit, Healthcare
Associated Infections and Antimicrobial Resistance, Imperial College London,
Hammersmith Campus, W12 ONN, UK.
E-mail address: e.charani@imperial.ac.uk (E. Charani).
https://doi.org/10.1016/j.ijid.2020.08.057
1201-9712/© 2020 The Author(s). Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).in low- and middle-income countries (LMICs) (O’Neill, 2016).
Healthcare-associated infections (HCAI), caused by drug-resistant
pathogens, are associated with increased morbidity and mortality,
length of hospital stay, and cost (Holmes et al., 2015; O’Neill, 2016).
They also contribute to increased emotional and mental burdens
on patients (Mo et al., 2019). Inconsistent infection prevention and
control (IPC) practices and suboptimal antibiotic use remain key
areas of concern across high-income countries (HICs) and LMICs
(Katwyk et al., 2020). In addition to being integral to AMR
containment, IPC is a universal component of all health systems,
affecting the health and safety of both people who seek the
healthcare services and those who provide them. This has
implications for antimicrobial stewardship (AMS) at various levels.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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action plans, have yet to fully exploit strategic approaches
necessary for building the critical capacity and contingency for
responsive and sustainable policies and interventions that can be
transferred to multiple contexts (Ahmad et al., 2019). At the meso
level, hospital-based AMS programmes are not consistently
implemented, or well-integrated with IPC (Charani et al., 2019a).
This is despite the fact that these programmes are proven to be
effective in improving the quality and safety of patient care
through increased infection cure rates, reduced treatment failures,
and increased frequency of appropriate prescribing for treatment
and prophylaxis (Davey et al., 2017). Reasons for this inconsistency
vary according to the resources available for AMS programmes and
the prevailing context in the implementation setting. The current
ongoing severe acute respiratory syndrome coronavirus (SARS-
CoV-2) pandemic (causing coronavirus disease-2019; COVID-19)
has exposed the gaps in current IPC strategies, highlighting the
need for robust investment and capacity building in IPC as as well
strategies to tackle AMR. The pandemic may potentiate the long-
term threat of AMR (Rawson et al., 2020). As part of efforts to
control for suspected underlying bacterial infections in patients
with COVID-19 infection, treating physicians may prescribe
antibiotics more often, thereby unintentionally exposing the
patient to selective pressure and AMR.
International partnerships in research and other collaborations
are critical to global efforts to tackle AMR. Sustained efforts in
strategies for IPC and AMS are essential at hospital (e.g. staff and
management), national, and international levels, spanning from
policy to implementation (Katwyk et al., 2020; Cox et al., 2017). The
SARS-CoV-2 pandemic has changed the research landscape and the
ability to deliver international research programmes. For example,
since the emergence of the pandemic the majority of the UK
Department for International Development (DFID) staff posted
abroad have had to return to the UK, severely impeding the
operational delivery of projects in partner countries (Whitehead,
2020). The UK government’s decision to merge DFID with the
Foreign Office also poses threats to long-term funding and
opportunities for international collaborations. This is at a time
when greater global partnership and collaboration in health care
had been gaining speed. At the 68th World Health Assembly held in
Geneva in 2015, a Global Action Plan on AMR was adopted, in
response to recognition of the need to address AMR across a One
Health agenda. Later that year, AMR was included as a threat to the
UN sustainable development goals (SDGs) (Børge and Bent, 2015).
Although omitted from specific SDG targets, AMR is mentioned in
paragraph 26, which highlights AMR as part of the problem of
unattended diseases affecting developing countries (Kassebaum
et al., 2016; Jasovský et al., 2016). Several of the SDGs are directly
linked to AMR, including good health and wellbeing (SDG3), clean
water and sanitation (SDG6), industry, innovation and infrastruc-
ture (SDG 9), and reduced inequalities (SDG10). Building research
capacity—key to operationalizing strategies and interventions to
tackle AMR across different countries—feeds into SDGs 9 and 10.
The need for research collaborations to tackle AMR in LMICs
In many LMICs, additional challenges impede the research,
implementation and evaluation of effective strategies to tackle
AMR, especially at the organisational level (Charani et al., 2019a;
Cox et al., 2017; Charani et al., 2019b; Pulcini et al., 2019). These
include the lack of a robust healthcare infrastructure (e.g. staff
workforce, access to clinical microbiology laboratory facilities, and
mechanisms for disease surveillance). Governments completely or
partially control activities that promote, restore, and maintain
health; in most cases, governments are the primary funders and
the providers of health services. In countries where non-governmental organisations do operate, inadequate local capacity
building can lead to a lack of synergy between local and
international programmes. This then puts the sustainability of
such programmes at risk, for example when external funding dries
up or when faced with external threats such as pandemics. Health
strategies in LMICs focus on promoting population-level public
health through social and community mobilization, and provision
of treatment through hospitals and clinics in the public sector. Due
to more constrained health budgets, LMICs are expected to provide
essential rather than comprehensive health services (Kruk et al.,
2018). This restricts the national governments to primarily
assessing the evolving trends and emerging threats of infectious
diseases (Seale et al., 2017), with limited resources to further
operationalize and sustain AMS programmes. While large regional
AMR surveillance networks have been established in Europe
(EARSNet), Latin America (Red Latinoamericana de Vigilancia de la
Resistencia a los Antimicrobianos, ReLAVRA), and Central Asia and
Eastern Europe (CAESAR), capacity for AMR surveillance in low-
income countries is relatively limited and fragmented; this is
despite evidence that AMR in low-income regions is increasing
(Leung et al., 2011). Research is often hampered by inadequate
investments by the government and external funders with regard
to the required human resource skills and expertise, equipment,
and surveillance and feedback strategies to inform practice.
Coordination between researchers and policymakers remains
inefficient and this can translate into inadequate evidence
generation, synthesis and translation, and application to practice
(May, 2013; Mannion and Davies, 2018). Significant patient load,
high patient:provider ratios, and lack of sustained training in
antimicrobial stewardship and pharmacotherapy can hinder
sustainable and long-term improvement in care (Kakkar et al.,
2020). Furthermore, the research rarely engages with patients and
carers, whose perspective is often missing (Cook et al., 2019).
However, there are valuable lessons to be learnt from the
innovations and resilience of healthcare systems in LMICs that
have been able to implement successful change in tackling AMR, in
spite of the challenges that they face. Some of these challenges
remain universal. For example, the issue of access to and correct
use of diagnostic laboratories is of particular concern in LMICs, and
remains suboptimal in all settings. Geographical logistics can limit
provision of laboratory services in both high- and low-resource
settings (Skodvin et al., 2017). Where there is access to diagnostic
laboratories, incidences of unnecessary testing as well as antibiotic
prescribing in the absence of any microbiology tests results remain
high (Skodvin et al., 2019; Charani et al., 2019c). Solutions to
overcome these challenges have been reported in LMICs, an
example being in Vietnam where an internationally funded and
established research collaboration has been successful in deliver-
ing a sustainable AMS programme, including enhanced laboratory
capacity (Wertheim et al., 2013). This is an example of how
collective efforts in AMR, supported by greater international
collaboration at the policy, research, synthesis and translation, and
implementation levels, can lead to sustainable improvements. In
the face of diminishing resources, capacity building, supported by
funding, should be an integral part of AMR containment and
mitigation efforts.
Capacity building in AMS and IPC research through
collaboration
Building capacity for AMR research and AMS development, and
its strategic implementation and adoption, requires a One World
agenda and approach. Incorporating interdisciplinary, intersec-
toral, and international collaboration is critical. Key to spanning
AMR efforts from global to local is the development of reciprocal,
long-term, supported partnerships between collaborators in LMICs
280 P. Veepanattu et al. / International Journal of Infectious Diseases 100 (2020) 278–282and HICs (Prentiss et al., 2018). Partnerships that enable learning
across LMICs are needed, as solutions developed in an LMIC context
are most likely to have most relevance and transferability to other
LMIC settings. The ESSENCE on Health Research criteria developed
by funding agencies to improve coordination of research capacity
investment in LMICs provides an effective template for building
research collaborations relating to AMR (ESSENCE, 2014). ESSENCE
on Health Research is an initiative that allows donors and funders
to increase the value of resources in LMICs, by identifying synergies
and establishing coherence across human research programmes.
The ESSENCE Seven Principles of capacity building for research in
LMICs is the model supported by the WHO. Research capacity
strengthening is a long-term process, which can often make it
difficult to attribute causes and contributions. Additionally,
resilience has to be built in to enable systems and collaborations
to absorb the shock of unexpected events, such as pandemics. The
ESSENCE Seven Principles of of capacity building for research in
LMICs are summarised in Box 1, and focus on networking,
communication, monitoring and evaluation, research governance,
strong support and mentorship structures, and flexibility for
resilience and continuity. Drawing on our collaborative research
across India, South Africa, and the UK, we have evaluated our
experience of capacity building for research in IPC and AMS,
building on the ESSENCE principles. Developing equal partnerships
is critical to fostering resilient and responsive teams, with the
potential for sustainable research synthesis, implementation, and
translation across international institutions.
Here we use two case studies to evaluate how the ESSENCE
principles can support collaborative research in AMS and IPC at
both local and international levels. The first case study is based on a
public–private partnership for implementing AMS in the state of
Kerala in India, and the second is based on a research partnership
investigating the meso and macro drivers for implementing AMS
across surgical pathways in India and South Africa. These case
studies also demonstrate a commitment to delivering programmes
through earmarked funding. Case study 1 highlights local
commitment through providing funding for adequate staffing,
including pharmacists, as part of a comprehensive AMS team,
which in the long term proved to be cost-effective. Case study 2
demonstrates the added value of funding bodies assigning and
supporting greater international collaborations in AMR by inves-
ting in the development of the local workforce.
Case study 1: implementing antimicrobial stewardship in a
hospital in Kerala, India
The state of Kerala, in the southern India, was the first in the
country to implement a state-wide strategy for addressing AMR
through AMS. The AMS programme in Kerala is an example of an
effective capacity building programme for tackling AMR, demon-
strating the influence of collaborative partnership and effectiveBox 1. The ESSENCE seven principles for strengthening research
Network, collaborate, communicate, and share experiences alig
Understand the local context and accurately evaluate existing re
Ensure local ownership and secure active support align="none"
Build in monitoring, evaluation, and learning from the start alig
Establish robust research governance and support structures, a
Embed strong support, supervision, and mentorship structures 
Think long term, be flexible, and plan for continuity align="noneleadership (Figure 1). Through a 7-year campaign (beginning in
2013), led by a state-level clinical champion, an AMS program with
a strong stakeholder network and robust participation was created
across professional societies (Singh et al., ARIC; under review) and
public–private partnerships in secondary care. At hospital level, an
effective leadership drive ensured the inclusion of all stakeholders
from different specialties and professional groups (including
laboratory, pharmacy, and nursing) (Singh et al., 2019). Including
representatives from different specialties in AMS and IPC
committees assured local ownership and integration of local
contexts into interventions. At the state level, capacity was
developed in regional laboratories to participate in the Indian
Council of Medical Research (ICMR) AMR surveillance network.
Laboratory staff were trained through a bespoke programme
developed in partnership with the Kerala Department of Health to
ensure uniform data with respect to AMR surveillance. The
initiative was incremental, beginning with stakeholder engage-
ment and buy-in from political to clinical leadership, followed by
establishment of policy and guidelines, a comprehensive state-
wide post-graduate training programme for doctors, and then local
capacity building for AMS within hospitals (Singh et al., ARIC;
under review).
Effective training was provided at hospital and state level to all
medical graduates. Additionally, at the participating private and
public hospitals, a train-the-trainer model was created to assure
the transfer of knowledge and skills. In the lead hospital, an
effective monitoring and evaluation programme included embed-
ding mechanisms to ensure effective tools for monitoring out-
comes, comprising an antibiogram app, feedback forms for
antibiotic prescribing, and pharmacist-driven reviews of prescrib-
ing practices (Singh et al., 2019). Long-term sustainability for the
AMS programme was achieved through recruiting competent
human resources, including trained clinical pharmacists, in the
stewardship programme. Whilst this approach has proven
successful in Kerala, it is important to recognize that the health
system in India is diverse and there may be other successful AMS
models in place.
Case study 2: an international collaboration tackling AMR
across surgical pathways
The ASPIRES collaboration (Antibiotic use across Surgical
Pathways—Investigating, Redesigning and Evaluating Systems;
https://www.imperial.ac.uk/arc/aspires/) is an example of an
externally funded partnership that was developed through smaller
studies, including student exchange programmes. The collabora-
tion aims to improve clinical outcomes by optimizing antibiotic
usage along surgical pathways, working across South Africa, the
UK, and India (Charani et al., 2017). The research study was
codesigned with surgical, IPC, and AMS leads in each setting




nd promote effective leadership align="none"
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Figure 1. Two case studies of AMS research and implementation (supported by local and international funding) measured against, and building upon, the ESSENCE principles
for capacity building.
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the leadership approach was structured to provide mentorship and
support to researchers across the three countries. An initial intense
phase of face-to-face training was undertaken in each setting,
involving 2 months’ training for local teams by experienced
researchers. This was followed with regular check-in meetings (via
video link) to monitor both the development and progress of the
researchers as well as the project. The mentorship mix included
cross-disciplinary teams (doctors, implementation scientists,
social scientists, nurses, and pharmacists) to provide a broad
range of expertise. The more senior researchers also gained skills in
global health research, operationalization and leadership, which
allowed for the different cadres of researchers to assess and
provide feedback on the skills of their colleagues. Learning from
the research was shared through a codeveloped virtual learning
platform (Massive Open Online Course: https://www.futurelearn.
com/courses/social-science-for-tackling-antimicrobial-resis-
tance). This model has proven to be effective and resilient to
unexpected obstacles in the process, including lack of access to
specific sites by some researchers due to visa restrictions and the
unintended consequence of the SARS-CoV-2 pandemic on travel
restrictions. Investing equally in research resources in each setting
enabled a sustained research presence in South Africa and India,
facilitating data gathering as well as developing long-standing
professional relationships. Furthermore, international training
workshops were supplemented with virtual workshops, where
all researchers could participate in the implementation process in
each setting. The emphasis on enabling and encouraging
collaborations between early career researchers across the three
sites ensured South–South and North–South knowledge transfer
with regard to research methodologies and skills required to
strengthen the overall capacity for AMR research. These newly
gained skills also supported local AMS programs and experientiallearning. This international collaboration has not been without its
logistical issues, in terms of travel and language barriers; these
have been overcome through greater use of technology and the
invaluable input of local teams.
Investing in capacity building has assured sustained delivery of
the program through the current SARS-CoV-2 pandemic, including
the imposed travel restrictions, allowing the flexibility to realign
the research to meet immediate needs in each setting. Further-
more, historic close collaborations between the principal inves-
tigators and country leads played a key role in delivering this
project.
Conclusions
In building collaborations to address AMR, organizations need
to ensure that the strengthening of research capacity remains an
explicit objective, from consultations with the funders to
implementation of research findings. Potential strategies that
have been recognized include the promotion of good research
governance, emphasis on the relevance of strategic partnership,
and the fostering of good networking and collaborations between
the funding agencies and the recipient organizations.
Engaging with local stakeholders (including patients and the
public) as part of research synthesis, implementation, and
evaluation provides a deeper understanding of the political and
cultural research environment, ascertaining the potential facili-
tators and barriers to various initiatives for strengthening research
capacity. This can be through identifying the demand for research
by examining the policy process and identifying the barriers to
greater use of evidence by policy makers. Such involvement will
promote buy-in across the network, as well as ensuring feasibility
and sustainability of necessary interventions identified from
research-informed findings.
282 P. Veepanattu et al. / International Journal of Infectious Diseases 100 (2020) 278–282Actively seeking to build national and international collaborations
that transcend traditional academic and clinical boundaries, and
which recognize that little can be achieved by working in silos, will
support mentorship of cadres of multi-professional researchers, adept
at communicating across disciplines. Strong, self-sustaining, peer
groupsupportforearlycareerresearchersthatfacilitates learninginan
environment characterized by openness and mutual respect is
essential to developing resilient systems for research that can work
inhealthcareenvironmentsat increasingthreatofdisruption,e.g. from
pandemics. In the efforts to establish AMS research and learning, it is
crucial to account for multiple disciplines, and provide opportunity
and mentorship both within and outside of disciplines. The case
studies presented incorporate key infrastructure developments in
laboratory surveillance capacities and requisite training to enhance
resource personnel competence for IPC activities and AMR research, in
conjunction with knowledge sharing through regional expertise
networks and multinational collaborations. Our comprehensive
approach of implementing, evaluating, and building upon the
ESSENCE criteria for capacity building for research in the context of
AMR can provide a sustainable, resilient platform for research and
patient-centered care in low-resource settings.
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